无礼回复
发表于 2025-3-26 23:16:57
http://reply.papertrans.cn/20/1906/190592/190592_31.png
敏捷
发表于 2025-3-27 03:51:16
Breast Reconstructionisions regarding the timing, type, and extent of reconstruction. The gold standard for breast cancer care includes an integrated multidisciplinary team approach comprising surgical oncologists, medical oncologists, radiation oncologists, oncology nurses, and plastic surgeons.
Arb853
发表于 2025-3-27 05:18:11
http://reply.papertrans.cn/20/1906/190592/190592_33.png
BULLY
发表于 2025-3-27 10:20:32
http://reply.papertrans.cn/20/1906/190592/190592_34.png
参考书目
发表于 2025-3-27 16:13:04
Biopsy Techniques in Non-palpable or Palpable Breast Lesionsc benign lesions or when coring biopsy tools fail to provide adequate diagnostic information and material. Ductoscopy, which was initially developed as a tool to investigate pathological nipple discharge, is an evolving technology that may have an increasing role in research and prevention as tools
乐器演奏者
发表于 2025-3-27 19:29:55
Staging of Breast Cancerof ongoing TNM staging to determine whether to apply systemic therapy based on anatomic prognosis. Although multigene expression assays, such as the 70-gene prognostic signature or Oncotype DX tests, may provide additional prognostic and predictive information beyond anatomic TNM staging and ER/PR a
截断
发表于 2025-3-27 22:59:20
http://reply.papertrans.cn/20/1906/190592/190592_37.png
巨头
发表于 2025-3-28 04:17:50
Adjuvant Systemic Chemotherapy for HER2-Negative Diseasegimen depends on the intrinsic subtype. Multigene expression array profiling is not always required for subtype definition after clinicopathological assessment. Young age, grade 3 disease, lymphovascular invasion, one to three positive nodes, and large tumor size are not adequate features to omit mo
Muffle
发表于 2025-3-28 09:31:56
http://reply.papertrans.cn/20/1906/190592/190592_39.png
infringe
发表于 2025-3-28 10:34:30
Adjuvant Radiation Therapy After Preoperative Chemotherapynal treatment), selected patients (cT1–2, cN1, and >40 years old) with pathological complete response (pCR) (ypT0, ypTis, ypN0) and non-triple-negative histology after neoadjuvant chemotherapy could possibly be followed without postmastectomy radiotherapy (PMRT) and without regional irradiation in a